Gestion de la biologie délocalisée lors de la première vague de Covid-19 en France. Résultats de l’enquête nationale menée par le groupe de travail des EBMD de la SFBC (notice n° 275501)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04961cam a2200481 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250117193350.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Glady, Ludovic |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Gestion de la biologie délocalisée lors de la première vague de Covid-19 en France. Résultats de l’enquête nationale menée par le groupe de travail des EBMD de la SFBC |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2021.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 68 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Au printemps 2020, lors de la première vague de Covid-19 en France, les laboratoires de biologie médicale des établissements de santé ont dû s’adapter rapidement aux demandes de biologie d’urgence par notamment une réorganisation de leur parc de biologie délocalisée : redéploiement d’analyseurs et/ou nouvelles installations. Afin d’analyser cette gestion, un sous-groupe de 15 biologistes hospitaliers, issu du groupe de travail de la SFBC « Marqueurs biochimiques de Covid-19 », a diffusé à l’automne 2020 un questionnaire informatisé à destination des laboratoires de CH et CHU utilisateurs d’EBMD. L’analyse des réponses ( n = 86) montre une disparité territoriale en fonction de la sévérité de la première vague : augmentation d’activité prédominante en zone rouge, gestion de situations inédites, formation de personnel soignant supplémentaire pour 40 % des laboratoires... L’enquête a montré la mise en place presque générale d’un allègement des aspects liés à l’accréditation en période de crise sanitaire. Une enquête complémentaire, réalisée au printemps 2021, a montré une bonne satisfaction globale des services de soins ( n = 139) vis-à-vis des services rendus par la biologie dans le secteur des EBMD. De par leur grande capacité d’adaptation, les laboratoires et leurs équipes en charge des EBMD ont joué un rôle primordial dans la gestion de la première vague de Covid-19. La réussite de ces organisations nécessite, cependant, une indispensable collaboration entre les laboratoires et les services de soins. Les résultats de cette enquête sont fondamentaux dans un contexte de prolongation de la pandémie au niveau mondial, avec un secteur des EBMD apparaissant en pleine croissance. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | During the first wave of Covid-19 in France, in spring 2020, healthcare institution's laboratory had to adapt itself quickly to the growing demand for emergency biology, in particular by reorganizing their POCT analyzers: redeployment of analyzers and/or new installations. In order to analyze this management, a subgroup of 15 hospital biologists from the SFBC Working Group “Biochemical markers of Covid-19” sent, in fall 2020, an on-line survey to French hospital laboratories using POCT. Answers analysis ( n = 86) shows a territorial disparity related to the severity of the first wave: increased activity essentially in red zones, management of unexpected situations, training of additional nursing staff for 40 % of the laboratories... The survey also showed simplification of aspects related to accreditation those periods of health crisis. An additional survey, carried out in the spring of 2021, showed good overall satisfaction of the healthcare services ( n = 139) concerning the services provided by biology in the POCT sector. Because of their great adaptation capacity, the laboratories and their POCT-teams have played a key role in the management of the first wave of Covid-19 in France. However, the success of these organizations requires an essential collaboration between laboratories and healthcare services. The results of this survey are fundamental in the context of the prolongation of the pandemia throughout the world with a POCT sector appearing to be growing. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | biologie délocalisée |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | enquête nationale |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | EBMD |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | gestion de crise |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | POCT |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | crisis management |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | national survey |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moal, Valérie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Benz-de Bretagne, Isabelle |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bouvier, Damien |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Di Giovanni, Flore |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chenevier-Gobeaux, Camille |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jeannesson, Elise |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jolly, Emilie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kadi, Habiba |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Oueidat, Nathalie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pernet, Pascal |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Piéroni, Laurence |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Poupon, Carole |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Toussaint-Hacquard, Marie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dubos, Mickaël |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martinel, Isabelle |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chauzit, Emmanuelle |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Beauvieux, Marie-Christine |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Annales de Biologie Clinique | 79 | 6 | 2021-12-01 | p. 535-549 | 0003-3898 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-annales-de-biologie-clinique-2021-6-page-535?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-annales-de-biologie-clinique-2021-6-page-535?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux